Regulatory Expertise Amin Wasserman Gurnani specializes in FDA, food and beverage, nutraceutical, cosmetic, medical device, and pharmaceutical regulatory matters, making them a strategic partner for clients navigating complex compliance, labeling, and advertising requirements.

Lifecycle Counsel The firm offers end-to-end support from product development and regulatory approvals to post-launch compliance, recalls, and enforcement actions, suggesting opportunities to upsell comprehensive risk management and ongoing compliance services.

Industry Focus Target sectors include raw juices, hemp products, nutraceuticals, and innovative medical devices, aligning with growing market segments and potential clients seeking specialized regulatory guidance.

Strategic Partnerships Recent alliance with Hansem Global indicates appetite for cross-border and multilingual regulatory navigation, signaling a pathway to expand services for international manufacturers entering the U.S. market.

Growth Profile Revenue estimated at 10–25 million with a leaner firm size (11–50 employees) suggests an opportunity to scale advisory services, including expansion into broader litigation support, IP strategy, and large-scale regulatory programs for mid-market clients.